Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1988-2-20
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0304-4246
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
247-53
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3121249-Buserelin,
pubmed-meshheading:3121249-Endometriosis,
pubmed-meshheading:3121249-Estradiol,
pubmed-meshheading:3121249-Female,
pubmed-meshheading:3121249-Fertility,
pubmed-meshheading:3121249-Genital Neoplasms, Female,
pubmed-meshheading:3121249-Humans,
pubmed-meshheading:3121249-Ovulation
|
pubmed:year |
1987
|
pubmed:articleTitle |
LH-RH agonist treatment of endometriosis.
|
pubmed:affiliation |
Hôpital St-François-d'Assise, Université Laval, Québec, Canada.
|
pubmed:publicationType |
Journal Article
|